SAN JOSE, Calif.–(BUSINESS
WIRE)–Baxano, Inc., a Silicon Valley based medical device company and
manufacturer of the iO-Flex® System for spinal decompression surgery, announced
today that it has received a medical device license (license # 88060) from
Health Canada permitting the company to promote its iO-Flex technology
Baxanos flagship iO-Flex System is the first minimally
invasive set of flexible instruments designed to target lumbar stenosis in the
central canal, lateral recess, and neural foramen with minimal disruption to
the patients healthy anatomy critical for maintaining spinal stability. It is
the only treatment alternative that is able to reach and remove tissue that
creates pressure on multiple nerve roots through a single laminotomy.
“The Canadian marketplace offers Baxano an excellent
opportunity to expand the presence of our iO-Flex System to patients suffering
from the painful effects of lumbar spinal stenosis,” said Tony Recupero,
President & CEO of Baxano. “We believe that the iO-Flex technology has the
potential to revolutionize the care of patients with stenosis. Preliminary data
from our post market studies, suggest that the iO-Flex System may help reduce
the overall health costs associated with the treatment of patients with lumbar
spinal stenosis. Its gratifying to now be able to offer this less-invasive
solution for lumbar stenosis to spine surgeons and their patients in Canada.”
The complete iO-Flex system is on display this week at the
2012 Annual Meeting of the American
Academy of Orthopaedic
Surgeons (AAOS) in Baxanos booth # 511.
Lumbar Spinal Stenosis is a degenerative medical condition
in which the spinal canal narrows and compresses the spinal cord and nerves in
the lumbar area of the spine. Symptoms include pain, weakness, numbness, and
tingling in the lower back and legs.
Decompression surgery is a common procedure used to treat
lumbar spinal stenosis by cutting away overgrown bone and tissue causing
pressure on the spinal nerves. Approximately 325,000 surgical procedures
involving decompression to treat lumbar stenosis are performed each year in the
The arrival of the iO-Flex System introduces a less-invasive, surgeon- and
For more information about Baxano, the iO-Flex System or the
companys post-market clinical trials, please visit: www.baxano.com or contact media relations representative
Paul Williams at 310/569-0023 or email@example.com.
About Baxano, Inc.
Baxano, Inc., based in San Jose, California, is a privately held company, which
was founded in 2005 with the vision to create flexible tools to provide
precision lumbar decompression from the “inside out.” These platform
technologies will form the basis for future product offerings. Baxanos mission
is to develop innovative tools that restore spine function, preserve healthy
tissue, and enable a better quality of life for patients.
Along with its dedication to advanced technology
development, Baxano is focused on providing exceptional value to patients,
customers, investors, and employees.